PDF icon Download PDF
Nuklearmedizin 2025; 64(03): 228-230
DOI: 10.1055/a-2543-0846
Case Report

A Case of Male Breast Cancer Detected by Myocardial Perfusion Scintigraphy

Ahmet Eren Şen
1   Department of Nuclear Medicine, Konya City Hospital, Konya, Turkey (Ringgold ID: RIN591703)
,
Fatma Hicret Tekin
2   Department of Pathology, Konya City Hospital, Konya, Turkey (Ringgold ID: RIN591703)
,
Mustafa Erol
1   Department of Nuclear Medicine, Konya City Hospital, Konya, Turkey (Ringgold ID: RIN591703)
,
Ülkünur Çimen Şen
3   Department of Pathology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey (Ringgold ID: RIN64222)
› Author Affiliations
› Further Information
Also available ateRef
   Permissions and Reprints
Preview

Introduction

Technetium-99m methoxyisobutyl isonitrile (Tc-99m MIBI) is widely used in myocardial perfusion scintigraphy (MPS) and parathyroid scintigraphy (PS). Tc-99m MIBI is also known to accumulate in malignant tissues, particularly in breast cancer. Here, we present a male patient who underwent MPS imaging and was subsequently diagnosed with breast cancer thanks to focal radiotracer uptake observed in the breast region. Additionally, we briefly discuss male breast cancer in the context of this case. To the best of our knowledge, no prior cases of male breast cancer diagnosed through MPS have been reported in the literature.



Publication History

Received: 02 November 2024

Accepted after revision: 19 February 2025

Article published online:
12 March 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Ionescu S, Nicolescu AC, Marincas M. et al. An Update on the General Features of Breast Cancer in Male Patients-A Literature Review. Diagnostics (Basel) 2022; 12 (07) 1554
    Search in Google Scholar
  • 2 Abdelwahab Yousef AJ. Male Breast Cancer: Epidemiology and Risk Factors. Semin Oncol 2017; 44 (04) 267-272
    Search in Google Scholar
  • 3 AlFehaid M. Male Breast Cancer (MBC) – A Review. Pol Przegl Chir 2023; 95 (06) 24-30
    Search in Google Scholar
  • 4 Fentiman I. Male breast cancer: a review. Ecancermedicalscience 2009; 3: 140
    Search in Google Scholar
  • 5 Fentiman IS. Surgical options for male breast cancer. Breast Cancer Res Treat 2018; 172: 539-544
    Search in Google Scholar
  • 6 Lin AP, Huang TW, Tam KW. Treatment of male breast cancer: meta-analysis of real-world evidence. Br J Surg 2021; 108 (09) 1034-1042
    Search in Google Scholar
  • 7 Yalaza M, İnan A, Bozer M. Male Breast Cancer. J Breast Health 2016; 12 (01) 1-8
    Search in Google Scholar
  • 8 Hassett MJ, Somerfield MR, Baker ER. et al. Management of male breast cancer: ASCO guideline. J Clin Oncol 2020; 38: 1849-1863
    Search in Google Scholar
  • 9 Khan MH, Allerton R, Pettit L. Hormone therapy for breast cancer in men. Clin Breast Cancer 2015; 15: 245-250
    Search in Google Scholar
  • 10 Moadel RM. Breast cancer imaging devices. Semin Nucl Med 2011; 41: 229-241
    Search in Google Scholar
  • 11 Khalkhali I, Villanueva-Meyer J, Edell SL. et al. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med 2000; 41: 1973-1979
    Search in Google Scholar
  • 12 Yoon HJ, Kim Y, Lee JE. et al. Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging. Eur Radiol 2015; 25: 32-40
    Search in Google Scholar
  • 13 Fukumoto M. Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin. Ann Nucl Med 2004; 18: 79-95
    Search in Google Scholar
  • 14 Kim IJ, Bae YT, Kim SJ. et al. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses. Oncology 2006; 70: 403-410
    Search in Google Scholar